Dr. Samuel Ludwin
Dr. Samuel Ludwin went to medical school at the University of Witwatersrand, Johannesburg, South Africa, and followed this with residency and fellowship training in Pathology and Neuropathology at Stanford University in California. Since 1975 he has been at Queen's University and Kingston General Hospital where he was a Professor of Pathology and Molecular Medicine until July 2010. He has specialized in research, teaching and the clinical practice of Neuropathology. At Queen's, Dr. Ludwin also served as Associate Dean (Research) in the Faculty of Health Sciences, and as Vice-President (Research Development) Kingston General and Hotel Dieu Hospitals. His major investigative interest has been in the field of Multiple Sclerosis, in which he has carried out both basic experimental research and clinical studies. His research work has been on around mechanisms of remyelination and demyelination as well as oligodendrocyte and astrocyte behaviour in clinical Multiple Sclerosis and its models. In July 2010, he became Professor Emeritus at Queen's University.
Dr. Ludwin is Past-Chair of the Medical Advisory Board of the Multiple Sclerosis Society of Canada and has served on the Research Development Committee of the National Multiple Sclerosis Society of the United States. He is currently on the Board of Directors of the Multiple Sclerosis Society of Canada, and on other related research foundations. He has served and continues to be on the editorial boards of numerous scientific journals. He is also a Past-President of the International Society of Neuropathology.
Dr. Ludwin has taught Medical Ethics to medical students and residents at Queen's and served on the Hospital ethics committees. He has written research ethics briefs for the Research Deans of the Association of Faculties of Medicine of Canada. He was a member of the Interagency Advisory Panel on Research Ethics from 2005 to 2012.
- Date modified: